Examining the Effects of Regular Brief Internet-based Meditation Practice on Mental Health and Well Being

April 15, 2024 updated by: Manish Saggar, Stanford University

An Internet-administered Randomized Control Trial to Examine the Effects of Regular, Brief Meditation Practice on Mental Health and Well Being

The study will examine the effects of online meditation training on stress and anxiety in healthy participants. It will also examine the dose-response relationship between the amount of daily focused attention meditation practice and established mental health outcome measures.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

This is a 16-week study with an 8-week meditation intervention, with a requirement of a minimum of 10 minutes of meditation practice each day. This study will recruit ~200 healthy subjects (18+ years) with no current or previous diagnosis of psychiatric or neurological disorders who are interested in learning about meditation but don't have long-term experience with meditation. Half of the participant pool will be randomly assigned to the meditation intervention, and the other half will get the wait-list control assignment. The control group will later receive its intervention, likely a few weeks after the completion of the active group's intervention. A focused-attention meditation technique (SOS meditation) will be used to train participants.

Changes in participants' physiological markers (e.g., HRV, physical activity, respiration rate, sleep quality) will be evaluated using passive activity monitoring devices (e.g., Fitbit). Intervention-related changes in mental health will be assessed using web-based mental health and well-being surveys. Improvements in cognitive functioning will be assessed using web-based psychological tasks.

Study Type

Interventional

Enrollment (Estimated)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Stanford, California, United States, 94305
        • Recruiting
        • Dept. of Psychiatry, Stanford University
        • Contact:
        • Principal Investigator:
          • Manish Saggar, Ph.D.
        • Principal Investigator:
          • David Spiegel, M.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age ≥ 18 years
  • Able to follow basic instructions for prescreening and scheduling
  • Compliant with investigator instructions during the consent process and participation in the study
  • Is not already a regular meditation practitioner

Exclusion Criteria:

  • Age <18
  • People with a current diagnosis of psychiatric or neurological disorders
  • Be in current psychiatric treatment or medications
  • Hospitalized for psychiatric disorders in the past year or so.
  • Regular and long-term meditation practitioners
  • Non-English speaking
  • Non-USA mailing address to receive the activity tracker device
  • Vision or hearing impairment severe enough to interfere with study participation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Meditation group

Baseline to week 8:

Subjects will be trained to meditate for 10 minutes daily, and several measures (questionnaires, cognitive tests, and physiological measurements) will be obtained to assess the efficacy of daily meditation practice on mental health and well being. Focused-attention meditation technique will be used to train participants. Specifically the SOS meditation technique will be employed.

Week 8 to week 16:

Subjects will self report if they choose to continue SOS meditation and several measures (questionnaires, cognitive tests, and physiological measurements) will be obtained to assess the impact of continued meditation practice on mental health and well being.

Focused-attention meditation technique will be used to train participants, specifically the SOS meditation technique. The SOS meditation technique is an easy-to-learn approach where participants are instructed to dissociate their attention from physical awareness, thoughts, and emotions by mentally slowly repeating a calming word or phrase (chosen by the participant themselves).

SOS Meditation Instructions:

  • Close your eyes very gently, in a relaxed way, as you do when we go to sleep
  • Your attention should be fully alert. Try not to put any strain on your eyes or try to look up.
  • Focus your eyes about eight to ten inches into the field of darkness in front of you on the horizontal plane
  • Mentally repeat the (chosen) calming word
  • Sit lovingly and calmly to see what comes up, as if you were watching a movie screen and waiting to see what appears on it.
Experimental: Waitlist control

Baseline to week 8:

Subjects will be place in a control group which receives no intervention. However, several measures (questionnaires, cognitive tests, and physiological measurements) will be obtained to assess baseline mental health and well being scores.

Week 8 to week 16:

Subjects will be trained to meditate for 10 minutes daily, and several measures (questionnaires, cognitive tests, and physiological measurements) will be obtained to assess the efficacy of daily meditation practice on mental health and well being. Focused-attention meditation technique will be used to train participants. Specifically the SOS meditation technique will be employed.

Focused-attention meditation technique will be used to train participants, specifically the SOS meditation technique. The SOS meditation technique is an easy-to-learn approach where participants are instructed to dissociate their attention from physical awareness, thoughts, and emotions by mentally slowly repeating a calming word or phrase (chosen by the participant themselves).

SOS Meditation Instructions:

  • Close your eyes very gently, in a relaxed way, as you do when we go to sleep
  • Your attention should be fully alert. Try not to put any strain on your eyes or try to look up.
  • Focus your eyes about eight to ten inches into the field of darkness in front of you on the horizontal plane
  • Mentally repeat the (chosen) calming word
  • Sit lovingly and calmly to see what comes up, as if you were watching a movie screen and waiting to see what appears on it.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Generalize Anxiety Disorder Questionnaire Score
Time Frame: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Anxiety as measured using Generalize Anxiety Disorder Questionnaire
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Change in Pittsburgh Sleep Quality Index Questionnaire Score
Time Frame: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Sleep Quality measured using Pittsburgh sleep quality index (PSQI)
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Change in Mind Wandering Questionnaire Score
Time Frame: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Mind wandering measured using the Mind Wandering Questionnaire
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Resting Heart Rate
Time Frame: Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
Daily obtained from Activity Tracker wrist band
Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
Heart Rate Variability
Time Frame: Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
Daily obtained from Activity Tracker wrist band
Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
Change in Stroop Test Score
Time Frame: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Using the Stroop test, which measures the average reaction time between incongruent and congruent trials
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Change in N-back Test Score
Time Frame: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Using the N-back test is a memory task where participants must remember letters from N trials ago.
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Stress Scale Measure Questionnaire Score
Time Frame: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Stress measured using Perceived Stress Scale measure
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Change in Depression Questionnaire Score
Time Frame: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Depression measured using Patient Health Questionnaire
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Change in Quality of Life Scale Measures Questionnaire Score
Time Frame: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Quality of life measured using Quality of Life Scale measures
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Change Social Connectedness Scale-Revised Questionnaire Score
Time Frame: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Social Connectedness measured using Social Connectedness Scale-Revised
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Change in Rumination Reflection Questionnaire Score
Time Frame: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Rumination and reflection scales measured using Rumination Reflection Questionnaire
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Change in Brief Strengths Scale Questionnaire Score
Time Frame: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Strengths scale measured using Brief Strengths Scale measures individuals' Temperance Strength, Intellectual Strength, and Interpersonal Strength.
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
Change in Sleep Quality Measure
Time Frame: Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
Daily obtained from Activity Tracker wrist band
Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Manish Saggar, PhD, Stanford University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2023

Primary Completion (Estimated)

September 30, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

August 23, 2023

First Submitted That Met QC Criteria

August 23, 2023

First Posted (Actual)

August 28, 2023

Study Record Updates

Last Update Posted (Actual)

April 17, 2024

Last Update Submitted That Met QC Criteria

April 15, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 68784

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on SOS Meditation

3
Subscribe